A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
Public ClinicalTrials.gov record NCT06832618. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children and adolescents (6 to \<18 Years Old) with moderate atopic dermatitis.
Study identification
- NCT ID
- NCT06832618
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 159 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 17, 2025 (Actual)
- Primary completion
- Aug 7, 2026 (Actual)
- Completion
- Sep 6, 2027 (Estimated)
- Last update posted
- Aug 19, 2026
2025 – 2027
United States locations
- U.S. sites
- 20
- U.S. states
- 16
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Center of Alabama | Birmingham | Alabama | 35209 | — |
| Saguaro Dermatology | Phoenix | Arizona | 85008 | — |
| National Jewish Health | Denver | Colorado | 80206 | — |
| Encore Medical Research, Llc Hollywood | Hollywood | Florida | 33024 | — |
| Lane Dermatology and Dermatologic Surgery | Columbus | Georgia | 31904 | — |
| Cleaver Medical Group | Cumming | Georgia | 30040 | — |
| Treasure Valley Medical Research | Boise | Idaho | 83706 | — |
| Sneeze Wheeze and Itch Associates Llc | Normal | Illinois | 61761 | — |
| Endeavor Health Medical Group | Skokie | Illinois | 60077 | — |
| Raven Clinical Research | Marriottsville | Maryland | 21104 | — |
| Oakland Hills Dermatology Pc | Auburn Hills | Michigan | 48326 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39216 | — |
| Red River Research Partners | Bolivar | Missouri | 65613 | — |
| Medisearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| University of Rochester Medical Center | Rochester | New York | 14620 | — |
| Cincinnati Childrens Hospital Medical Center | Cincinnati | Ohio | 45229 | — |
| University of Texas Physicians - Bellaire Station | Bellaire | Texas | 77401 | — |
| Frontier Dermatology | Mill Creek | Washington | 98012 | — |
| Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 73 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06832618, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 19, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06832618 live on ClinicalTrials.gov.